Lastly, while G-Bro shows promise in inhibiting BACE1 and preventing Aβ aggregation, the interaction with other pathways involved in Alzheimer’s disease pathology, such as tau aggregation or neuroinflammation, was not investigated in this study. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.